|
1
|
Kaul A, Gordon C, Crow MK, Touma Z,
Urowitz MB, van Vollenhoven R, Ruiz-Irastorza G and Hughes G:
Systemic lupus erythematosus. Nat Rev Dis Primers. 2:160392016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dörner T and Furie R: Novel paradigms in
systemic lupus erythematosus. Lancet. 393:2344–2358. 2019.
View Article : Google Scholar
|
|
3
|
Alexander JJ, Jacob A, Chang A, Quigg RJ
and Jarvis JN: Double negative T cells, a potential biomarker for
systemic lupus erythematosus. Precis Clin Med. 3:34–43. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chesnutt MS, Finck BK, Killeen N, Connolly
MK, Goodman H and Wofsy D: Enhanced lymphoproliferation and
diminished autoimmunity in CD4-deficient MRL/lpr mice. Clin Immunol
Immunopathol. 87:23–32. 1998. View Article : Google Scholar
|
|
5
|
Nagasu A, Mukai T, Iseki M, Kawahara K,
Tsuji S, Nagasu H, Ueki Y, Ishihara K, Kashihara N and Morita Y:
Sh3bp2 Gain-Of-function mutation ameliorates lupus phenotypes in
B6.MRL-Faslpr Mice. Cells. 8:4022019. View Article : Google Scholar
|
|
6
|
Benihoud K, Bonardelle D, Bobé P and Kiger
N: MRL/lpr CD4-CD8− and CD8+ T cells,
respectively, mediate Fas-dependent and perforin cytotoxic
pathways. Eur J Immunol. 27:415–420. 1997. View Article : Google Scholar
|
|
7
|
Martina MN, Noel S, Saxena A, Rabb H and
Hamad AR: Double negative (DN) αβ T cells: Misperception and
overdue recognition. Immunol Cell Biol. 93:305–310. 2015.
View Article : Google Scholar
|
|
8
|
Corneth OBJ, Schaper F, Luk F, Asmawidjaja
PS, Mus AMC, Horst G, Heeringa P, Hendriks RW, Westra J and
Lubberts E: Lack of IL-17 Receptor A signaling aggravates
lymphoproliferation in C57BL/6 lpr mice. Sci Rep. 9:40322019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shaltout AS, Sayed D, Badary MS, Nafee AM,
El Zohri MH, Bakry R and Ahmed SH: Effect of IL6 and IL23 on double
negative T cells and anti ds-DNA in systemic lupus erythematosus
patients. Hum Immunol. 77:937–943. 2016. View Article : Google Scholar
|
|
10
|
Brandt D and Hedrich CM: TCRαβ
+ CD3 + CD4−CD8−
(double negative) T cells in autoimmunity. Autoimmun Rev.
17:422–430. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Getachew Y, Cusimano FA, James LP and
Thiele DL: The role of intrahepatic
CD3+/CD4−/CD8-double negative T (DN T) cells
in enhanced acetaminophen toxicity. Toxicol Appl Pharmacol.
280:264–271. 2014. View Article : Google Scholar
|
|
12
|
Hedrich CM, Rauen T, Crispin JC, Koga T,
Ioannidis C, Zajdel M, Kyttaris VC and Tsokos GC: cAMP-responsive
element modulator α (CREMα) trans-represses the transmembrane
glycoprotein CD8 and contributes to the generation of CD3+CD4-CD8-T
cells in health and disease. J Biol Chem. 288:31880–31887. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hedrich CM, Crispín JC, Rauen T, Ioannidis
C, Koga T, Rodriguez Rodriguez N, Apostolidis SA, Kyttaris VC and
Tsokos GC: cAMP responsive element modulator (CREM) α mediates
chromatin remodeling of CD8 during the generation of CD3+CD4-CD8-T
cells. J Biol Chem. 289:2361–2370. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Merino R, Fossati L, Iwamoto M, Takahashi
S, Lemoine R, Ibnou-Zekri N, Pugliatti L, Merino J and Izui S:
Effect of long-term anti-CD4 or anti-CD8 treatment on the
development of lpr CD4-CD8-double negative T cells and of the
autoimmune syndrome in MRL-lpr/lpr mice. J Autoimmun. 8:33–45.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ohteki T, Iwamoto M, Izui S and MacDonald
HR: Reduced development of CD4-8-B220+ T cells but normal
autoantibody production in lpr/lpr mice lacking major
histocompatibility complex class I molecules. Eur J Immunol.
25:37–41. 1995. View Article : Google Scholar
|
|
16
|
Trimble LA, Prince KA, Pestano GA, Daley J
and Cantor H: Fas-dependent elimination of nonselected CD8 cells
and lpr disease. J Immunol. 168:4960–4967. 2002. View Article : Google Scholar
|
|
17
|
Koh DR, Ho A, Rahemtulla A, Fung-Leung WP,
Griesser H and Mak TW: Murine lupus in MRL/lpr mice lacking CD4 or
CD8 T cells. Eur J Immunol. 25:2558–2562. 1995. View Article : Google Scholar
|
|
18
|
Ezine S, Lucas B, Vicari A, Dautigny N,
Vasseur F and Penit C: A novel CD45RA+CD4+
transient thymic subpopulation in MRL-lpr/lpr mice: Its relation to
non-proliferating CD4-CD8-CD45RA+ tumor cells. Int
Immunol. 5:89–96. 1993. View Article : Google Scholar
|
|
19
|
Grishkan IV, Ntranos A, Calabresi PA and
Gocke AR: Helper T cells down-regulate CD4 expression upon chronic
stimulation giving rise to double-negative T cells. Cell Immunol.
284:68–74. 2013. View Article : Google Scholar
|
|
20
|
Zhang D, Yang W, Degauque N, Tian Y,
Mikita A and Zheng XX: New differentiation pathway for
double-negative regulatory T cells that regulates the magnitude of
immune responses. Blood. 109:4071–4079. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu L, Takeda K and Akkoyunlu M: Disease
stage-specific pathogenicity of CD138 (Syndecan 1)-expressing T
cells in systemic lupus erythematosus. Front Immunol. 11:15692020.
View Article : Google Scholar
|
|
22
|
Seagal J, Leider N, Wildbaum G, Karin N
and Melamed D: Increased plasma cell frequency and accumulation of
abnormal syndecan-1plus T-cells in Igmu-deficient/lpr mice. Int
Immunol. 15:1045–1052. 2003. View Article : Google Scholar
|
|
23
|
Mohamood AS, Bargatze D, Xiao Z, Jie C,
Yagita H, Ruben D, Watson J, Chakravarti S, Schneck JP and Hamad
AR: Fas-mediated apoptosis regulates the composition of peripheral
alphabeta T Cell repertoire by constitutively purging out double
negative T cells. PLoS One. 3:e34652008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lu LD, Stump KL, Wallace NH, Dobrzanski P,
Serdikoff C, Gingrich DE, Dugan BJ, Angeles TS, Albom MS, Mason JL,
et al: Depletion of autoreactive plasma cells and treatment of
lupus nephritis in mice using CEP-33779, a novel, orally active,
selective inhibitor of JAK2. J Immunol. 187:3840–3853. 2011.
View Article : Google Scholar
|
|
25
|
Calame KL: Plasma cells: Finding new light
at the end of B cell development. Nat Immunol. 2:1103–1108. 2001.
View Article : Google Scholar
|
|
26
|
Pan Z, Chen M, Zhang Q, Wang E, Yin L, Xu
Y, Huang Q, Yuan Y, Zhang X, Zheng G and Yuan J: CD3-positive
plasmablastic B-cell neoplasms: A diagnostic pitfall. Mod Pathol.
31:718–731. 2018. View Article : Google Scholar
|
|
27
|
Tsokos GC, Lo MS, Costa Reis P and
Sullivan KE: New insights into the immunopathogenesis of systemic
lupus erythematosus. Nat Rev Rheumatol. 12:716–730. 2016.
View Article : Google Scholar
|
|
28
|
Eisenberg RA, Craven SY, Warren RW and
Cohen PL: Stochastic control of anti-Sm autoantibodies in
MRL/Mp-lpr/lpr mice. J Clin Invest. 80:691–697. 1987. View Article : Google Scholar
|
|
29
|
Eisenberg RA, Craven SY and Cohen PL:
Isotype progression and clonality of anti-Sm autoantibodies in
MRL/Mp-lpr/lpr mice. J Immunol. 139:728–733. 1987.
|
|
30
|
Pinheiro SVB, Dias RF, Fabiano RCG, Araujo
SA and Silva ACSE: Pediatric lupus nephritis. J Bras Nefrol.
41:252–265. 2018.(In English, Portuguese). View Article : Google Scholar
|
|
31
|
Wilhelmus S, Bajema IM, Bertsias GK,
Boumpas DT, Gordon C, Lightstone L, Tesar V and Jayne DR: Lupus
nephritis management guidelines compared. Nephrol Dial Transplant.
31:904–913. 2016. View Article : Google Scholar
|
|
32
|
Mok CC, Yap DY, Navarra SV, Liu ZH, Zhao
MH, Lu L, Takeuchi T, Avihingsanon Y, Yu XQ, Lapid EA, et al:
Overview of lupus nephritis management guidelines and perspective
from Asia. Int J Rheum Dis. 16:625–636. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dammacco R: Systemic lupus erythematosus
and ocular involvement: An overview. Clin Exp Med. 18:135–149.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu Y, He S, Bai B, Zhang L, Xue L, Lin Z,
Yang X, Zhu F, He P, Tang W and Zuo J: Therapeutic effects of the
artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition
of TLR-triggered B-cell activation and plasma cell formation. Cell
Mol Immunol. 13:379–390. 2016. View Article : Google Scholar
|
|
35
|
Kilkenny C, Browne W, Cuthill IC, Emerson
M and Altman DG; NC3Rs Reporting Guidelines Working Group, : Animal
research: Reporting in vivo experiments: The ARRIVE guidelines. Br
J Pharmacol. 160:1577–1579. 2010. View Article : Google Scholar
|
|
36
|
Zhang P, Su L, Ma F, Ji X, Su Y, Yue Q,
Zhao C, Zhang S, Sun X and Zhao L: Weilan gum oligosaccharide
ameliorates dextran sulfate sodium-induced experimental ulcerative
colitis. Mol Med Rep. 25:522022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tilstra JS, Avery L, Menk AV, Gordon RA,
Smita S, Kane LP, Chikina M, Delgoffe GM and Shlomchik MJ:
Kidney-infiltrating T cells in murine lupus nephritis are
metabolically and functionally exhausted. J Clin Invest.
128:4884–4879. 2018. View Article : Google Scholar
|
|
38
|
Ehrenstein MR, Cook HT and Neuberger MS:
Deficiency in serum immunoglobulin (Ig)M predisposes to development
of IgG autoantibodies. J Exp Med. 191:1253–1258. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Carroll MC: A protective role for innate
immunity in systemic lupus erythematosus. Nat Rev Immunol.
4:825–831. 2004. View Article : Google Scholar
|
|
40
|
Yoshizawa Y, Honda S and Shibuya A:
Involvement of Fcα/µR (CD351) in autoantibody production. Mol
Immunol. 57:216–219. 2014. View Article : Google Scholar
|
|
41
|
Boes M, Schmidt T, Linkemann K, Beaudette
BC, Marshak-Rothstein A and Chen J: Accelerated development of IgG
autoantibodies and autoimmune disease in the absence of secreted
IgM. Proc Natl Acad Sci USA. 97:1184–1189. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang X, Deriaud E, Jiao X, Braun D,
Leclerc C and Lo-Man R: Type I interferons protect neonates from
acute inflammation through interleukin 10-producing B cells. J Exp
Med. 204:1107–1118. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Menon M, Blair PA, Isenberg DA and Mauri
C: A regulatory feedback between plasmacytoid dendritic cells and
regulatory B cells Is aberrant in systemic lupus erythematosus.
Immunity. 44:683–697. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wu HM, Wang J, Zhang B, Fang L, Xu K and
Liu RY: CpG-ODN promotes phagocytosis and autophagy through JNK/P38
signal pathway in Staphylococcus aureus-stimulated macrophage. Life
Sci. 161:51–59. 2016. View Article : Google Scholar
|
|
45
|
Akiyama C, Tsumiyama K, Uchimura C, Honda
E, Miyazaki Y, Sakurai K, Miura Y, Hashiramoto A, Felsher DW and
Shiozawa S: Conditional upregulation of IFN-α alone Is sufficient
to induce systemic lupus erythematosus. J Immunol. 203:835–843.
2019. View Article : Google Scholar
|
